I would expect updates on any or all of those to come in the form of a shareholder letter. All of the focus is currently on CRC because it is the fastest possible route to approval we have at the moment if the trial performs well. If it just performs so-so then I would think a phase 3 in mTNBC with an ICI or a phase 3 in CRC (probably also with an ICI depending on the findings) would be the next step and we would likely need a partner for that.
So, the next really newsworthy event will likely be a shareholder letter. The 10-K didn't come out until August last year so I hope we don't have to wait until then for the shareholder letter. We also don't know what we don't know so a partnership could be announced out of the blue or they could do a one-off PR about any number of things that the previous shareholder letters have addressed.